Literature DB >> 29470469

Acceptability of electronic cigarettes as an option to replace tobacco smoking for alcoholics admitted to hospital for detoxification.

Penelope Truman1, Moira Gilmour2, Geoffrey Robinson3.   

Abstract

AIM: A feasibility/acceptability trial was undertaken at Ward 5, Kenepuru Hospital, Porirua, to ascertain whether electronic cigarettes (e-cigarettes) were a useful option to replace or reduce smoking in the detoxification ward.
METHODS: Two groups of patients were studied. Tobacco use and dependency data were collected for each. The first group was surveyed on the usefulness of standard nicotine replacement therapy (NRT). The second group were offered e-cigarettes with the option of standard NRT as well. All were asked to record their use of cigarettes, e-cigarettes and NRT during their stay on the ward, and to comment on their experiences. Outcomes monitored were self-reported use of NRT and of tobacco. Informal impressions of the nursing staff were also collected, where offered. For the e-cigarette group, a blood sample was taken on day 3 or 4 of their stay in hospital for nicotine/cotinine analysis, to confirm nicotine intake status.
RESULTS: E-cigarettes were well tolerated as a form of nicotine replacement, eliciting positive comments, though they were not effective for all. The average reduction in median cigarettes per day was very similar between the group given standard NRT and the e-cigarette group, at 80% and 86% respectively. There were no adverse effects reported.
CONCLUSION: The study showed that e-cigarettes were an acceptable form of nicotine replacement for these alcohol-dependent patients during their time in the ward. For heavily tobacco-dependent smokers, e-cigarettes may provide a useful aid to patient management within a hospital setting.

Entities:  

Mesh:

Year:  2018        PMID: 29470469

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  1 in total

Review 1.  Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Christine F McDonald; Stuart Jones; Lutz Beckert; Billie Bonevski; Tanya Buchanan; Jack Bozier; Kristin V Carson-Chahhoud; David G Chapman; Claudia C Dobler; Juliet M Foster; Paul Hamor; Sandra Hodge; Peter W Holmes; Alexander N Larcombe; Henry M Marshall; Gabrielle B McCallum; Alistair Miller; Philip Pattemore; Robert Roseby; Hayley V See; Emily Stone; Bruce R Thompson; Miranda P Ween; Matthew J Peters
Journal:  Respirology       Date:  2020-07-26       Impact factor: 6.424

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.